SKF-89626 is a highly selective full agonist of the dopamine D1 receptor of the thienopyridine family. However, the drug only weakly crosses the blood–brain barrier. SKF-89615 and SKF-89626 were the first selective and full-efficacy dopamine D1 receptor agonists to be discovered. They were first described in the scientific literature by David E. Nichols and colleagues in 1985.
See also SKF-89,145
References